KRAS G12C LUNG CANCER

Clinical trials for KRAS G12C LUNG CANCER explained in plain language.

Never miss a new study

Get alerted when new KRAS G12C LUNG CANCER trials appear

Sign up with your email to follow new studies for KRAS G12C LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New drug cocktail targets tough lung cancer before and after surgery

Disease control Not yet recruiting

This study tests whether giving a combination of targeted drugs and chemotherapy before and after surgery can improve outcomes for people with a specific genetic subtype of lung cancer (KRAS G12C mutation). About 32 adults with stage IB to IIIB lung cancer that can be removed wil…

Matched conditions: KRAS G12C LUNG CANCER

Phase: PHASE2 • Sponsor: Guangdong Provincial People's Hospital • Aim: Disease control

Last updated May 17, 2026 02:02 UTC

KRAS G12C LUNG CANCER

Get alerted when new KRAS G12C LUNG CANCER trials appear

New drug cocktail targets tough lung cancer before and after surgery